Clinical Research Site

Jacksonville, Florida 32256

8 studies enrolling now · 20 studies all time

What they study most

ADHD, Agitation in Patients With Dementia of the Alzheimer's Type, Binge-Eating Disorder, Depression, Fibromyalgia, Major Depressive Disorder, Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms, Migraine, Pulmonary Aspergillosis, Refractory IPA, Thyroid Eye Disease, Treatment Resistant Depression

Studies at this site

• Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol — Recruiting now
• Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol — Recruiting now
• A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD — Recruiting now
• A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia — Enrolling by invitation
• An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) — Completed
• Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study) — Stopped early
• A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS) — Completed
• Initiating Early Control of Migraine Pain and Associated Symptoms — Completed
• Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
• Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder — Enrolling by invitation
• Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED) — Completed
• Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
• A Trial of AXS-05 in Patients With Major Depressive Disorder — Completed
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
• Assessing Symptomatic Clinical Episodes in Depression — Completed